- Report
- February 2025
- 200 Pages
Global
From €3955EUR$4,490USD£3,476GBP
- Book
- October 2019
- 153 Pages
- Book
- November 2019
United States
- Book
- August 2020
Asia Pacific

The Human Diseases market is a subset of the Biology and Life Sciences industry that focuses on the diagnosis, treatment, and prevention of diseases in humans. It includes research and development of drugs, medical devices, and diagnostics, as well as the delivery of healthcare services. This market is driven by advances in medical technology, the emergence of new diseases, and the need for better treatments. It is also influenced by the availability of healthcare resources, the cost of treatments, and the changing demographics of the population.
The Human Diseases market is highly competitive, with a range of players from large pharmaceutical companies to small biotechnology firms. Companies in this market include Pfizer, Merck, Novartis, Johnson & Johnson, Roche, Sanofi, AstraZeneca, GlaxoSmithKline, AbbVie, and Bristol-Myers Squibb. Show Less Read more